A Greater Town : US : UN : International : United States Minor Outlying Islands : Community & Government : Energy & Environment : Environmental Services — Environmental Health & Safety Services

Breast Cancer Therapeutics Market Rapid Growth By Top International Players | AstraZeneca, Pfizer Inc., Sanofi, and more Forecast till 2025

Environmental Health & Safety Services

Updated on Sep 12, 2019

Edit post | View more like this | Visit United States Minor Outlying Islands, UN | Contact Fortune BI

The Global Breast Cancer Therapeutics Market, which stood at US$ 17,868.8 Mn in 2018, will reach [US$ 38,573.5 Mn] by the end of 2026. If these figures prove true, the global breast cancer therapeutics market will rise at a CAGR of 10.2% between 2018 and 2026.

Browse Complete Report Details @


North America to Remain Dominant on Account of Presence of Skilled Professionals

The increasing number of breast cancer cases all over the world is anticipated to boost the global breast cancer therapeutics market at promising rates, finds Fortune Business Insights in a new study. The study is titled, “Breast Cancer Therapeutics Market: Global Market Analysis, Insights, and Forecasts”.

The breast cancer treatment market in North America is currently leading the global landscape, supported by the presence of well-established healthcare infrastructure and rising uptake of advanced facilities in the region. In 2018, North America generated a revenue of US$ 8,033.8 Mn because of the increasing prevalence of breast cancer in the region.

In addition to this, the region boasts the presence of several leading market players and skilled professionals. Besides this, governments of developed nations such as Canada and the U.S. are providing health insurance for cancer diagnostics. Spurred by these factors the breast cancer therapeutics market is likely to flourish in North America to emerge dominant 

Key Segmentation:

By Therapy

  • Targeted Therapy

  • Abemaciclib

  • Ado-Trastuzumab Emtansine

  • Everolimus

  • Trastuzumab

  • Ribociclib

  • Palbociclib

  • Pertuzumab

  • Olaparib

  • Others

  • Hormonal Therapy

  • Selective Estrogen Receptor Modulators (SERMs)

  • Aromatase Inhibitors

  • Estrogen Receptor Downregulators (ERDs)

  • Chemotherapy 

By Distribution Channel

  • Hospital Pharmacies

  • Retail Pharmacies

  • Online Pharmacies

By Cancer Type

  • Hormone Receptor

  • HER2+

By Geography

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

goodideazs, LLC is not affiliated with the authors of this post nor is it responsible for its content, the accuracy and authenticity of which should be independently verified.

About | Advertise | Terms | Privacy | Contact A Greater Town

Top Business Listings | Banner Art Gallery | Blog

Copyright © 2007-2019 goodideazs, LLC. All rights reserved.